• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SNMMI Procedure Standard/EANM Practice Guideline for Fibroblast Activation Protein (FAP) PET.

作者信息

Hope Thomas A, Calais Jeremie, Goenka Ajit H, Haberkorn Uwe, Konijnenberg Mark, McConathy Jonathan, Oprea-Lager Daniela E, Trimnal Laura, Zan Elcin, Herrmann Ken, Deroose Christophe M

机构信息

Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California;

UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.

出版信息

J Nucl Med. 2025 Jan 3;66(1):26-33. doi: 10.2967/jnumed.124.269002.

DOI:10.2967/jnumed.124.269002
PMID:39572227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11705787/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f3/11705787/f13ad734988a/jnumed.124.269002f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f3/11705787/f13ad734988a/jnumed.124.269002f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f3/11705787/f13ad734988a/jnumed.124.269002f1.jpg

相似文献

1
SNMMI Procedure Standard/EANM Practice Guideline for Fibroblast Activation Protein (FAP) PET.SNMMI成纤维细胞活化蛋白（FAP）PET程序标准/EANM实践指南
J Nucl Med. 2025 Jan 3;66(1):26-33. doi: 10.2967/jnumed.124.269002.
2
Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0.《EANM/SNMMI/ANZSNM 联合实践指南/程序标准：在实体瘤患者接受免疫调节治疗期间推荐使用 [F]FDG PET/CT 成像（第 1.0 版）》
Eur J Nucl Med Mol Imaging. 2022 Jun;49(7):2323-2341. doi: 10.1007/s00259-022-05780-2. Epub 2022 Apr 4.
3
SNMMI Procedure Standard/EANM Practice Guideline for Brain [F]FDG PET Imaging, Version 2.0.SNMMI脑部[F]FDG PET成像程序标准/EANM实践指南，第2.0版。
J Nucl Med. 2024 Oct 17. doi: 10.2967/jnumed.124.268754.
4
SNMMI Procedure Standard/EANM Practice Guideline on Pediatric F-FDG PET/CT for Oncology 1.0.SNMMI 程序标准/EANM 实践指南：儿科肿瘤 1.0 版 F-FDG PET/CT
J Nucl Med. 2021 Jan;62(1):99-110. doi: 10.2967/jnumed.120.254110.
5
Role of [F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelines.[F]FDG PET/CT 在非特殊类型浸润性乳腺癌患者中的作用：文献复习及指南比较。
Breast. 2024 Dec;78:103806. doi: 10.1016/j.breast.2024.103806. Epub 2024 Sep 12.
6
International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology.国际核医学与分子影像学会（EANM）-美国核医学与分子影像学会（SNMMI）-国际磁共振医学学会（ISMRM）关于肿瘤PET/MRI的共识推荐
Eur J Nucl Med Mol Imaging. 2023 Oct;50(12):3513-3537. doi: 10.1007/s00259-023-06406-x. Epub 2023 Aug 25.
7
The SNMMI and EANM practice guideline for renal scintigraphy in adults.美国核医学与分子影像学会和欧洲核医学协会成人肾闪烁显像实践指南。
Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2218-2228. doi: 10.1007/s00259-018-4129-6. Epub 2018 Aug 30.
8
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0.EANM 实践指南/SNMMI 程序标准：帕金森综合征中多巴胺能成像 1.0 版。
Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1885-1912. doi: 10.1007/s00259-020-04817-8. Epub 2020 May 9.
9
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0.欧洲核医学协会（EANM）/欧洲神经肿瘤学会（EANO）/神经肿瘤放射治疗协作组（RANO）/核医学与分子影像学会（SNMMI）脑转移瘤PET成像联合实践指南/程序标准：第1.0版
Eur J Nucl Med Mol Imaging. 2025 Apr;52(5):1822-1839. doi: 10.1007/s00259-024-07038-5. Epub 2025 Jan 7.
10
SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors.SNMMI生长抑素受体PET程序标准/EANM神经内分泌肿瘤成像实践指南
J Nucl Med. 2023 Feb;64(2):204-210. doi: 10.2967/jnumed.122.264860.

引用本文的文献

1
Recent Advances in PET and Radioligand Therapy for Lung Cancer: FDG and FAP.肺癌正电子发射断层显像（PET）及放射性配体疗法的最新进展：氟代脱氧葡萄糖（FDG）与成纤维细胞活化蛋白（FAP）
Cancers (Basel). 2025 Aug 1;17(15):2549. doi: 10.3390/cancers17152549.
2
FAPI-positron emission tomography for radiotherapy in head and neck cancer: applications and future directions.头颈部癌放疗中的FAPI正电子发射断层扫描：应用与未来方向
Phys Imaging Radiat Oncol. 2025 Jun 5;35:100792. doi: 10.1016/j.phro.2025.100792. eCollection 2025 Jul.
3
Meeting Upcoming Clinical and Diagnostic Needs in Oncologic Imaging: A Structured Reporting System for Fibroblast-Activation-Protein-Targeted Imaging-FAP-RADS Version 1.0.

本文引用的文献

1
FAPI PET uptake patterns after invasive medical interventions: a single center retrospective analysis.侵袭性医学干预后 FAPI PET 摄取模式：单中心回顾性分析。
Eur J Nucl Med Mol Imaging. 2024 Sep;51(11):3373-3385. doi: 10.1007/s00259-024-06733-7. Epub 2024 May 16.
2
Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy.镓-成纤维细胞激活蛋白抑制剂 PET/CT 提高了对中低度肉瘤的检测能力，并确定了放射性药物治疗的候选者。
J Nucl Med. 2024 Jun 3;65(6):880-887. doi: 10.2967/jnumed.123.267248.
3
Ga-FAP-2286 PET of Solid Tumors: Biodistribution, Dosimetry, and Comparison with F-FDG.
满足肿瘤成像中即将到来的临床和诊断需求：成纤维细胞激活蛋白靶向成像的结构化报告系统——FAP-RADS版本1.0
J Nucl Med. 2025 Aug 1;66(8):1245-1251. doi: 10.2967/jnumed.125.269914.
4
Based on small molecules: development and application of fibroblast activation protein inhibitors radiopharmaceutical in tumor precision therapy.基于小分子：成纤维细胞活化蛋白抑制剂放射性药物在肿瘤精准治疗中的研发与应用
Front Pharmacol. 2025 May 14;16:1593380. doi: 10.3389/fphar.2025.1593380. eCollection 2025.
5
Head-to-head comparison of fibroblast activation protein inhibitors (FAPI) radiopharmaceuticals and [F]FDG in gynaecological malignancies: systematic literature review and meta-analysis.妇科恶性肿瘤中成纤维细胞活化蛋白抑制剂（FAPI）放射性药物与[F]FDG的头对头比较：系统文献综述与荟萃分析
Eur J Nucl Med Mol Imaging. 2025 Apr 25. doi: 10.1007/s00259-025-07277-0.
6
177Lu-LNC1004 Radioligand Therapy in Patients with End-stage Metastatic Cancers: A Single-Center, Single-Arm, Phase II Study.177Lu-LNC1004放射性配体疗法治疗终末期转移性癌症患者：一项单中心、单臂、II期研究。
Clin Cancer Res. 2025 Apr 14;31(8):1415-1426. doi: 10.1158/1078-0432.CCR-24-3918.
Ga-FAP-2286 PET 用于实体瘤：生物分布、剂量学和与 F-FDG 的比较。
J Nucl Med. 2024 Jun 3;65(6):938-943. doi: 10.2967/jnumed.123.267281.
4
Diagnostic Potential of Supplemental Static and Dynamic Ga-FAPI-46 PET for Primary F-FDG-Negative Pulmonary Lesions.静态和动态 Ga-FAPI-46 PET 对原发性 F-FDG 阴性肺部病变的诊断潜力。
J Nucl Med. 2024 Jun 3;65(6):872-879. doi: 10.2967/jnumed.123.267103.
5
Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study.镓标记的FAPI-04 PET-CT用于系统性硬化症相关间质性肺疾病中纤维母细胞活化的分子评估及风险评估：一项单中心试点研究
Lancet Rheumatol. 2021 Mar;3(3):e185-e194. doi: 10.1016/S2665-9913(20)30421-5. Epub 2021 Jan 25.
6
68Ga-FAPI PET imaging monitors response to combined TGF-βR inhibition and immunotherapy in metastatic colorectal cancer.68Ga-FAPI PET 成像监测转移性结直肠癌中 TGF-βR 抑制联合免疫治疗的反应。
J Clin Invest. 2024 Jan 4;134(4):e170490. doi: 10.1172/JCI170490.
7
Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT for the Early and Late Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Prospective Study.Ga 标记成纤维细胞激活蛋白抑制剂 PET/CT 对乳腺癌患者新辅助化疗后病理反应的早期和晚期预测：一项前瞻性研究。
J Nucl Med. 2023 Dec 1;64(12):1899-1905. doi: 10.2967/jnumed.123.266079.
8
Feasibility of acquisitions using total-body PET/CT with a half-dose [Ga]Ga-FAPI-04 activity in oncology patients.全身 PET/CT 半剂量 [Ga]Ga-FAPI-04 活性在肿瘤患者中的采集可行性。
Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):3961-3969. doi: 10.1007/s00259-023-06354-6. Epub 2023 Aug 3.
9
Comparing the clinical value of baseline [ Ga]Ga-FAPI-04 PET/CT and [F]F-FDG PET/CT in pancreatic ductal adenocarcinoma: additional prognostic value of the distal pancreatitis.对比基线 [68Ga]Ga-FAPI-04 PET/CT 和 [18F]F-FDG PET/CT 在胰腺导管腺癌中的临床价值：远端胰腺炎的附加预后价值。
Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):4036-4050. doi: 10.1007/s00259-023-06297-y. Epub 2023 Jul 26.
10
Current Status of Fibroblast Activation Protein Imaging in Gynecologic Malignancy and Breast Cancer.妇科恶性肿瘤和乳腺癌中成纤维细胞激活蛋白成像的现状。
PET Clin. 2023 Jul;18(3):345-351. doi: 10.1016/j.cpet.2023.03.005.